7 years ago my stomach system was upset due to change location of my home
after that mujhe bahut loose motion hone laga kafi dini tak
uske baad maine dawaiya li phir thik ho gaya magar us samay mere baal tutne lage the aur mere bhair lagte the jaise sacalp ek dum gila ho jata tha jaise ekdum dandruff se bhara gila
uske baad kuch baal tutthe the par utna nahi uske ek saal baad mujhe tyophid ho gaya
uska ilaaj hua uske ek saal baad mujhe jondis ho gaya wo thik ho gaya
uske baad se lagatar maine dawaiya khai homeopath ki magar koi result nahi aaya
aap please bataye ki mai kaun se dawai mere liye behtar hoga taki mere hair phir se regrow ho jaye
mai issse upset raha karta hoon
mere jab baal tutne start hue the us samay meri age 20 years thi
abhi to aap jaan hi gaye hai
please give me a right solution to cure my hair to hair fall and regain my hair
my hair fall from forehead
plase sir give me a solution
Human clinical trials are a critical phase to bringing safe and effective treatments to market. Many tests are conducted before the clinical trial stage to determine whether potential treatments are appropriate for testing in people. It is through clinical trials that safe and effective drugs, therapies and ultimately, a cure for alopecia areata will be discovered. By participating in a clinical trial, you play an important role in the fight to treat and cure alopecia areata. The decision to participate, however, is very personal and should be made only after speaking with your health care provider and other individuals you trust. You can stop participation in a clinical trial at any time if new concerns arise or you lose confidence that its potential benefits outweigh its risks.
The topical sensitizers, diphencyprone or squaric acid dibutylester, have been used in those suffering from recalcitrant alopecia areata or those with more than 50% hair loss. The goal of treatment is to create an allergic contact dermatitis of the scalp. This alteration in the immune response occasionally is accompanied by hair regrowth. The efficacy of the topical sensitizers has been demonstrated in both young children and adults, but it probably works less than half the time. Recent success using oral janus kinase inhibitors, including tofacitinib, ruxolitinib, and baricitinib, have been shown to be efficacious in severe, extensive alopecia areata in adults, but long-term therapy has potential side effects. The durability of response to these medications is variable, and most patients experience recurrence of hair loss after discontinuation. Perhaps topical therapy with these types of drugs may be available in the near future.